Is the randomized controlled drug trial in Europe lagging behind the USA?

British Journal of Clinical Pharmacology

Volumn 66, Issue 6, 2008, Pages 774-780

  Heerspink, Hiddo J Lambers ^a   Knol, Mirjam J ^b   Tijssen, Robert J W ^c   Van Leeuwen, Thed N ^c   Grobbee, Diederick E ^b   De Zeeuw, Dick ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Bibliometric analysis; Randomized controlled trial

Indexed keywords

ARTICLE; AUSTRALIA; BIBLIOMETRICS; CLINICAL STUDY; DATA BASE; DRUG INDUSTRY; DRUG SCREENING; EUROPE; FUNDING; GOVERNMENT; JAPAN; MEDICAL RESEARCH; MEDLINE; POPULATION SIZE; PRIORITY JOURNAL; PUBLICATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; UNITED STATES;

AUSTRALIA; BIBLIOMETRICS; BIOMEDICAL RESEARCH; DRUG INDUSTRY; EUROPE; FEMALE; FINANCING, GOVERNMENT; HUMANS; JAPAN; LINEAR MODELS; MALE; PERIODICALS AS TOPIC; PHARMACEUTICAL PREPARATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 56549116391     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03296.x     Document Type: Article

References (15)

1. Gluud C, Nikolova D. Likely country of origin in publications on randomised controlled trials and controlled clinical trials during the last 60 years. Trials 2007 8 : 7.
2. Organization for Economic co-operation and Development. OECD. Stat. Available at http://www.oecdorg/topicstatsportal (last accessed 4 April 2008).
3. European Commission Eurostat. European Commission Eurostat data. 2008. Available at http://epp.eurostat.ec.europa.eu (last accessed 13 April 2008).
4. European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures 2006. Available at http://www.efpia.org (last accessed 4 April 2008).
5. IMS Health. IMS World Health Review 2007. Norwalk, CT : IMS Health, 2007.
6. Soteriades ES, Falagas ME. Comparison of amount of biomedical research originating from the European Union and the United States. BMJ 2005 331 : 192 4.
7. Patsopoulos NA, Ioannidis JP, Analatos AA. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ 2006 332 : 1061 4.
8. Tijssen RJW. Internationalisation of pharmaceutical R&D: how globalised are Europe's largest multinational companies. Technol Anal Strat Manage 2008 forthcoming).
9. Watson R. Europe's research councils call for spending to be doubled to 0.25% of GDP. BMJ 2007 335 : 1232.
10. Lambers Heerspink HJ, Dobre D, Hillege HL, Grobbee DE, De Zeeuw D. Does the European Clinical Trials Directive really improve clinical trial approval time? Br J Clin Pharmacol 2008 66 : 546 50.
11. Reghar E. Ethical diversity and regulatory harmonisation: an empirical exploration of research ethics committees following the Directive of Good Clinical Practice. Available at http://www.sussexacuk/sociology/documents/ edreghar.pdf (last accessed 28 March 2008).
12. Centrale Commissie Mensgebonden Onderzoek. Centrale commissie mensgebonden onderzoek jaarverslag 2001. [Central Committee on Research Investigations in Human Subjects] Available at http://www.ccmo_online.nl/hipe/ uploads/downloads_catc/ccmo-jaarverslag-2001.pdf (last accessed: 30 March 2008).
13. Rahman M, Fukui T. A decline in the U.S. share of research articles. N Engl J Med 2002 347 : 1211 2.
14. Bardy AH. Report bias in drug research. Therapie 1996 51 : 382 3.
15. Decullier E, Lheritier V, Chapuis F. Fate of biomedical research protocols and publication bias in France: retrospective cohort study. BMJ 2005 331 : 19.